: This study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds' impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.

Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis

Mannella, Iole;Oliaro-Bosso, Simonetta;Pippione, Agnese C;Lolli, Marco L;Boschi, Donatella;
2023-01-01

Abstract

: This study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds' impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.
2023
Inglese
Esperti anonimi
13
9
1349
1366
18
AKR1C3; CYP17A1; enzyme inhibition; prostate cancer
POLONIA
   Pippione A. - Design di nuovi inibitori dUali contro il cancro alla prostata: progetto congiunto itaLo-polacco (DUAL).
   DUAL
   Ministero dell'Università e della Ricerca
   Pippione A. -

   Un nuovo bersaglio terapeutico per i tumori resistenti alle cure tradizionali: AKR1C3 (TORAK)
   TORAK
   FONDAZIONE CRT
   OLIARO S. - RF= 2022.0771
1 – prodotto con file in versione Open Access (allegherò il file al passo 6 - Carica)
262
17
Wróbel, Tomasz M; Sharma, Katyayani; Mannella, Iole; Oliaro-Bosso, Simonetta; Nieckarz, Patrycja; Du Toit, Therina; Voegel, Clarissa Daniela; Rojas Ve...espandi
info:eu-repo/semantics/article
open
03-CONTRIBUTO IN RIVISTA::03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
25) Tomasz CYP_AKR1C3.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 2.7 MB
Formato Adobe PDF
2.7 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1945833
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact